Cargando…
Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
INTRODUCTION: The aim of the current study was to evaluate the association of spironolactone and arterial stiffness and composite cardiovascular disease (CVD, including coronary heart disease, congestive heart failure and ischemic stroke) in hypertensive patients. MATERIAL AND METHODS: Baseline data...
Autores principales: | Zeng, Fanfang, Huang, Rong, Lu, Yongkang, Wu, Zhiye, Mai, Weiyi, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479706/ https://www.ncbi.nlm.nih.gov/pubmed/36160339 http://dx.doi.org/10.5114/aoms.2019.85661 |
Ejemplares similares
-
Association of anti-hyperuricemia treatment and prevalent cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019) -
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
por: Aryal, Sudeep R., et al.
Publicado: (2021) -
Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017) -
Arterial stiffness is associated with target organ damage in subjects with pre-hypertension
por: Wu, Shaoyun, et al.
Publicado: (2017) -
Spironolactone is superior to hydrochlorothiazide for blood pressure control and arterial stiffness improvement: A prospective study
por: Liu, Yan, et al.
Publicado: (2018)